Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, researchers have identified a vulnerability that opens ...

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

“For example, we know that if the cause is hepatitis B or C, there is a lot of evidence that your liver disease can improve if you get rid of the virus. Similarly, with alcohol, there is ...

Correspondence to Dr Guangchuan Wang, Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China; riverwang{at}126.com; Dr Shan Shan, Liver ...

Objectives This study aims to explore whether maternal hepatitis B carrier status is associated with an increased ... microcephalus, congenital heart disease and so on. According to a standardised and ...

alfred.org.au Background Unique immunological changes occur during pregnancy; the impact of which, on virological and biochemical markers of hepatitis B infection is not well ... is predominantly an ...

In the long term, regular binge drinking can also increase your risk of becoming dependent on alcohol, alcohol-related cancer and heart disease. Sign up to our fortnightly Heart Matters newsletter to ...

Although much research on the mechanisms of portal hypertension has focused on liver fibrosis, less attention has been given to the role of intrahepatic and extrahepatic ... Chronic hepatitis, ...

Heart disease and stroke remained the leading causes of death in the U.S. in 2022, outpacing the number of combined deaths from cancer and accidental deaths, according to the American Heart ...

Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus ... particularly B-cell depleting agents like rituximab, or disease. HBsAg-positivity also confers ...

A multicenter, prospective observational study of chemotherapy in elderly patients with biliary tract cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium.